share_log

Private Companies Invested in Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Copped the Brunt of Last Week's HK$960m Market Cap Decline

Private Companies Invested in Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Copped the Brunt of Last Week's HK$960m Market Cap Decline

私營公司投資于山東威高股份醫療聚合物有限公司(HKG:1066),承受了上週市值下跌96000萬港幣的主要衝擊
Simply Wall St ·  2024/11/26 06:58

Key Insights

主要見解

  • The considerable ownership by private companies in Shandong Weigao Group Medical Polymer indicates that they collectively have a greater say in management and business strategy
  • A total of 3 investors have a majority stake in the company with 51% ownership
  • 24% of Shandong Weigao Group Medical Polymer is held by Institutions
  • 山東威高醫療聚合物集團由私人公司持有的大量股份表明,他們共同在管理和業務策略中具有更大的發言權
  • 總計3名投資者持有該公司51%的所有權。
  • 山東威高醫療聚合物的24%股權由機構持有

A look at the shareholders of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) can tell us which group is most powerful. The group holding the most number of shares in the company, around 46% to be precise, is private companies. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

查看山東威高醫療聚合物有限公司(HKG:1066)的股東可以告訴我們哪個群體最有權力。公司中持有股份最多的群體,準確來說約佔46%,是私人公司。也就是說,如果股價上漲,則該群體將獲益最大(或在股價下跌時損失最多)。

As market cap fell to HK$20b last week, private companies would have faced the highest losses than any other shareholder groups of the company.

由於市值上週跌至200億港幣,私人公司可能面臨的損失比公司其他任何股東群體都要高。

Let's take a closer look to see what the different types of shareholders can tell us about Shandong Weigao Group Medical Polymer.

讓我們仔細看看不同類型股東能告訴我們關於山東威高股份醫療聚合物的什麼。

big
SEHK:1066 Ownership Breakdown November 25th 2024
SEHK:1066 2024年11月25日股權拆分

What Does The Institutional Ownership Tell Us About Shandong Weigao Group Medical Polymer?

機構持股告訴我們關於山東威高股份醫療聚合物的什麼?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。

We can see that Shandong Weigao Group Medical Polymer does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Shandong Weigao Group Medical Polymer's earnings history below. Of course, the future is what really matters.

我們可以看到山東威高股份醫療聚合物確實有機構投資者;他們持有公司股票的一部分。這意味着那些機構的分析師已經研究過這支股票,並且他們看好。但就像其他任何人一樣,他們也可能錯。如果多家機構同時改變對一支股票的看法,你可能會看到股價迅速下跌。因此值得查看山東威高股份醫療聚合物的歷史收入情況。當然,未來才是真正要緊的。

big
SEHK:1066 Earnings and Revenue Growth November 25th 2024
SEHK:1066 在2024年11月25日的收入和營業收入增長

Shandong Weigao Group Medical Polymer is not owned by hedge funds. Weihai Weigao International Medical Investment Holdings Limited is currently the largest shareholder, with 46% of shares outstanding. In comparison, the second and third largest shareholders hold about 3.2% and 2.2% of the stock.

山東威高醫用聚合物不是由對沖基金持有。威海威高國際醫療投資控股有限公司目前是最大股東,持有46%的股份。相比之下,第二和第三大股東持有大約3.2%和2.2%的股份。

To make our study more interesting, we found that the top 3 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

總的來說,包括散戶投資者在內,公衆擁有公司的14%的股份,因此不能輕易忽視。儘管這種所有權的規模可能不足以在他們的利益方面影響政策決策,但他們仍然可以對公司政策產生集體影響。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

我們的數據表明,私人公司持有公司的4.0%的股份。單單從這個事實上很難得出任何結論,因此它值得研究誰擁有這些私人公司。有時內部人或其他相關方通過單獨的私營公司持有上市公司的股份。

Insider Ownership Of Shandong Weigao Group Medical Polymer

山東威高醫用聚合物的內部持股情況

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

雖然內部人員的精確定義可能具有主觀性,但幾乎所有人都認爲董事會成員是內部人員。管理層最終向董事會負責。然而,如果經理是創始人或CEO,那麼他們成爲執行董事會成員並不罕見。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部人持股情況表明領導層思考和公司真正所有者一樣時,內部所有權是積極的。然而,高達內部人士所有權也可能爲公司內的小團體帶來巨大的權力。在某些情況下,這可能是負面的。

Our information suggests that Shandong Weigao Group Medical Polymer Company Limited insiders own under 1% of the company. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. It is a pretty big company, so it would be possible for board members to own a meaningful interest in the company, without owning much of a proportional interest. In this case, they own around HK$41m worth of shares (at current prices). Arguably, recent buying and selling is just as important to consider. You can click here to see if insiders have been buying or selling.

我們的信息顯示,山東威高醫療聚合物股份有限公司內部持有的股份不到公司總股本的1%。但我們注意到,內部人士通過私人公司或其他公司結構可能存在間接利益。這是一家相當大的公司,因此董事會成員可以擁有公司中的重要利益,而不擁有太多的比例利益。在這種情況下,他們持有大約4100萬港元的股份(按當前價格計算)。可以說,最近的買賣行爲同樣重要。您可以單擊此處查看內部人士是否一直在買入或賣出。

General Public Ownership

一般大衆所有權

With a 29% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Shandong Weigao Group Medical Polymer. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

擁有29%的股份,主要由個人投資者組成的普通公衆在山東威高醫療聚合物股份有限公司擁有一定的影響力。雖然這一群體不能必然決定事務,但確實可以對公司的運作產生實質影響。

Private Company Ownership

私有公司的所有權

Our data indicates that Private Companies hold 46%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我們的數據顯示,私人公司持有公司46%的股份。對此值得深入研究。如果相關方,如內部人員,在這些私人公司中有利益,那應在年度報告中披露。私人公司也可能對公司有戰略利益。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Shandong Weigao Group Medical Polymer , and understanding them should be part of your investment process.

儘管考慮擁有公司的不同群體非常重要,但還有更重要的因素。例如,要考慮投資風險這個永恒的幽靈。我們已經發現了威高股份醫療聚合物存在一個警告信號,了解這些應該是您投資過程的一部分。

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

如果您希望了解分析師在未來增長方面的預測,請務必不要錯過這份免費報告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論